CIR Panel Discusses Revised Ingredient Review Process
This article was originally published in The Rose Sheet
Executive Summary
The Cosmetic Ingredient Review Expert Panel devoted a substantial portion of its June 4-5 meeting in Washington, D.C. to discussing recent changes to the cosmetic ingredient review process
You may also be interested in...
FDA Surveying U.S. Cosmetic Products For Asbestos-Contaminated Talc
FDA is reviewing talc and talc-containing cosmetic products on the U.S. market for asbestos contamination following reports of the carcinogen in cosmetics overseas, according to an FDA spokesman
FDA Surveying U.S. Cosmetic Products For Asbestos-Contaminated Talc
FDA is reviewing talc and talc-containing cosmetic products on the U.S. market for asbestos contamination following reports of the carcinogen in cosmetics overseas, according to an FDA spokesman
CIR Reopens Shampoo Ingredient, Asks Industry About Impurity Levels
The Cosmetic Ingredient Review Expert Panel is reopening its safety assessment of cocamidopropylamine betaine (CAPB) due to concern about the presence of sensitizing impurities in the common shampoo ingredient, the panel announced during its April 16-17 meeting in Washington, D.C